% | $
Quotes you view appear here for quick access.

Bristol-Myers Squibb Company Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • fed_up_c_ws fed_up_c_ws Mar 25, 2011 1:40 PM Flag

    And the second pop ...

    BMY traded up to 27.97 in Sept/10, prior to sector rotation out of healthcare. Now that the economic recovery is less certain due to high oil costs and other factors, e.g., Japan, fund managers are rotating out of growth stocks and back into safer plays such as healthcare. If BMY was worth $28/share before the approval of Yervoy, its worth $30/share now. Actually 1B in Yervoy sales at the current PE should be worth $35/share.

59.47-1.14(-1.88%)Aug 31 4:02 PMEDT